Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis
Sophie A. Kitchen, Tonya Campbell, Siyu Men, Nikki Bozinoff, Mina Tadrous, Tony Antoniou, Jennifer Wyman, Dan Werb, Charlotte Munro, Tara Gomes
Topics & Concepts
Buprenorphine(+)-NaloxoneMethadoneMedicinePopulationPandemicEmergency medicineCoronavirus disease 2019 (COVID-19)OpioidAnesthesiaInternal medicineEnvironmental healthDiseaseReceptorInfectious disease (medical specialty)Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes